301211 亨迪药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.9163.9247.6025.5928.323
总资产报酬率 ROA (%)0.8563.6366.9815.2107.764
投入资产回报率 ROIC (%)0.9063.8717.4095.4778.244

边际利润分析
销售毛利率 (%)20.53528.84140.17228.87833.943
营业利润率 (%)7.43322.62630.96928.88425.764
息税前利润/营业总收入 (%)4.69411.37822.95515.96726.040
净利润/营业总收入 (%)6.56420.53326.56224.43022.502

收益指标分析
经营活动净收益/利润总额(%)1.22678.54096.29694.03384.775
价值变动净收益/利润总额(%)94.65818.9501.9820.0007.691
营业外收支净额/利润总额(%)-2.543-0.461-1.242-0.871-0.073

偿债能力分析
流动比率 (X)13.95211.40411.98410.66020.670
速动比率 (X)12.99610.56510.99210.11119.802
资产负债率 (%)5.9217.1917.4578.8954.614
带息债务/全部投入资本 (%)0.5230.4890.9322.9850.271
股东权益/带息债务 (%)18,887.42720,215.89110,560.3443,230.84136,672.936
股东权益/负债合计 (%)1,588.9771,290.5661,241.1041,024.2712,067.151
利息保障倍数 (X)-1.837-1.021-3.007-1.26088.477

营运能力分析
应收账款周转天数 (天)38.51340.80433.69670.74872.624
存货周转天数 (天)138.441176.813130.916100.365112.946